The invention relates to a method for inhibiting an in vivo alloimmune response, and to the use of a soluble recombinant human CD40L protein containing the active binding site with CD40. In particular, a soluble 18 KDa recombinant CD40L is used to inhibit an in vivo alloimmune response.

 
Web www.patentalert.com

< Chitosan and method of preparing chitosan

< Intracellular proteinacious antimicrobial agents from lactic acid bacteria derived from fermented food samples

> Brain associated inhibitor of tissue-type plasminogen activator

> Formulation for controlled release of drugs by combining hyrophilic and hydrophobic agents
~ 00279